US2016024534A1PendingUtilityA1
Increased Heterologous Fe-S Enzyme Activity in Yeast
Assignee: BUTAMAX ADVANCED BIOFUELS LLCPriority: Sep 29, 2008Filed: Oct 2, 2015Published: Jan 28, 2016
Est. expirySep 29, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Y02E50/10C12N 9/88C12Y 402/01009C12P 7/26C12P 7/16C12P 7/40C12N 1/18C12N 15/52
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A recombinant yeast host cell comprising at least two engineered modifications comprising:
(i) a heterologous dihydroxy-acid dehydratase Fe—S cluster protein expressed in the cytosol of the recombinant yeast host cell, wherein the heterologous dihydroxy-acid dehydratase Fe—S cluster protein is a polypeptide having an amino acid sequence that is at least 90% identical to SEQ ID NO: 183 or 185; and (ii) an endogenous Fe—S cluster protein with reduced expression, wherein the endogenous Fe—S cluster protein is dihydroxy-acid dehydratase.
26 . The recombinant yeast host cell of claim 25 , wherein the yeast is selected from the group consisting of Saccharomyces, Schizosaccharomyces, Hansenula, Candida, Kluyveromyces, Yarrowia , and Pichia.
27 . The recombinant yeast host cell of claim 25 , wherein the endogenous Fe—S cluster protein is expressed in the mitochondria.
28 . The recombinant yeast host cell of claim 25 , wherein the host cell is Saccharomyces that expresses a gene encoding a polypeptide having the amino acid sequence as set forth in SEQ ID NO: 183 or 185.
29 . The recombinant yeast host cell of claim 25 , wherein the cell comprises an isobutanol biosynthetic pathway.
30 . The recombinant yeast host cell of claim 29 , wherein the cell produces isobutanol.
31 . A method for the production of isobutanol comprising growing the recombinant yeast host cell of claim 30 , under conditions wherein isobutanol is produced.
32 . A method for the conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate comprising:
a) providing the recombinant yeast host cell of claim 25 and a source of 2,3-dihydroxyisovalerate; and
b) growing the recombinant host cell of a) with said source of 2,3-dihydroxyisovalerate under conditions where the 2,3-dihydroxyisovalerate is converted by the host cell to α-ketoisovalerate.Join the waitlist — get patent alerts
Track US2016024534A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.